Free Trial

Fractyl Health (GUTS) News Today

Fractyl Health logo
$2.84
+0.02 (+0.71%)
(As of 11/1/2024 ET)
Fractyl Health, Inc. stock logo
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Increase in Short Interest
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) saw a large growth in short interest in September. As of September 30th, there was short interest totalling 1,870,000 shares, a growth of 61.2% from the September 15th total of 1,160,000 shares. Based on an average trading volume of 356,500 shares, the short-interest ratio is presently 5.2 days. Currently, 9.4% of the company's stock are sold short.
The six worst foods for gut health
Fractyl Health, Inc. stock logo
Jay David Caplan Sells 65,000 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) insider Jay David Caplan sold 65,000 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $2.90, for a total transaction of $188,500.00. Following the transaction, the insider now directly owns 30,484 shares in the company, valued at $88,403.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Fractyl Health, Inc. stock logo
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Down 13.2% in August
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a significant decline in short interest in August. As of August 15th, there was short interest totalling 2,110,000 shares, a decline of 13.2% from the July 31st total of 2,430,000 shares. Currently, 10.6% of the company's shares are short sold. Based on an average daily trading volume, of 276,300 shares, the days-to-cover ratio is presently 7.6 days.
Fractyl Health, Inc. stock logo
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 5.7%
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 2,430,000 shares, an increase of 5.7% from the July 15th total of 2,300,000 shares. Currently, 12.2% of the shares of the company are short sold. Based on an average daily volume of 244,600 shares, the short-interest ratio is presently 9.9 days.
Get Fractyl Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.

Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).

GUTS Media Mentions By Week

GUTS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GUTS
News Sentiment

0.24

0.43

Average
Medical
News Sentiment

GUTS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GUTS Articles
This Week

3

4

GUTS Articles
Average Week

Get Fractyl Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GUTS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners